NYSE:TBI

TrueBlue Stock Forecast, Price & News

$25.90
-0.55 (-2.08 %)
(As of 09/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$25.63
$26.73
50-Day Range
$25.29
$28.26
52-Week Range
$14.99
$29.99
Volume253,571 shs
Average Volume185,400 shs
Market Capitalization$919.53 million
P/E Ratio22.92
Dividend YieldN/A
Beta1.69
30 days | 90 days | 365 days | Advanced Chart
Receive TBI News and Ratings via Email

Sign-up to receive the latest news and ratings for TrueBlue and its competitors with MarketBeat's FREE daily newsletter.


TrueBlue logo

About TrueBlue

TrueBlue, Inc. engages in the provision of staffing, recruitment process outsourcing and managed service provider solutions. It operates through the following segments: PeopleReady, PeopleManagement and PeopleScout. The PeopleReady segment offers staffing solutions for blue-collar, contingent on-demand and skilled labor to a broad range of industries that include retail, manufacturing, warehousing, logistics, energy, construction, hospitality and others. The PeopleManagement segment supplies contingent labor and outsourced industrial workforce solutions. The PeopleScout segment covers the provision of permanent employee recruitment process outsourcing for its customers for all major industries and jobs. The company was founded by John Ross Coghlan and Glenn Welstad in 1989 and is headquartered in Tacoma, WA.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.95 out of 5 stars

Business Services Sector

184th out of 392 stocks

Help Supply Services Industry

14th out of 20 stocks

Analyst Opinion: 1.3Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 2.5 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











TrueBlue (NYSE:TBI) Frequently Asked Questions

Is TrueBlue a buy right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TrueBlue stock.
View analyst ratings for TrueBlue
or view top-rated stocks.

What stocks does MarketBeat like better than TrueBlue?

Wall Street analysts have given TrueBlue a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but TrueBlue wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is TrueBlue's next earnings date?

TrueBlue is scheduled to release its next quarterly earnings announcement on Monday, October 25th 2021.
View our earnings forecast for TrueBlue
.

How were TrueBlue's earnings last quarter?

TrueBlue, Inc. (NYSE:TBI) released its earnings results on Sunday, July, 25th. The business services provider reported $0.47 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.39 by $0.08. The business services provider earned $515.96 million during the quarter. TrueBlue had a trailing twelve-month return on equity of 10.15% and a net margin of 2.01%.
View TrueBlue's earnings history
.

How has TrueBlue's stock been impacted by Coronavirus?

TrueBlue's stock was trading at $13.35 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TBI shares have increased by 94.0% and is now trading at $25.90.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for TBI?

5 Wall Street analysts have issued 1 year price objectives for TrueBlue's stock. Their forecasts range from $16.00 to $29.00. On average, they anticipate TrueBlue's stock price to reach $23.00 in the next twelve months. This suggests that the stock has a possible downside of 11.2%.
View analysts' price targets for TrueBlue
or view top-rated stocks among Wall Street analysts.

Who are TrueBlue's key executives?

TrueBlue's management team includes the following people:
  • A. Patrick Beharelle, President, Chief Executive Officer & Director
  • Derrek L. Gafford, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
  • Jeffrey S. Dirks, Chief Information & Technology Officer
  • Garrett R. Ferencz, Chief Legal Officer & Executive Vice President
  • Andrea Brogger, Chief People Officer & Senior Vice President

What is Patrick Beharelle's approval rating as TrueBlue's CEO?

34 employees have rated TrueBlue CEO Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among TrueBlue's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of TrueBlue's key competitors?

What other stocks do shareholders of TrueBlue own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

What is TrueBlue's stock symbol?

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Who are TrueBlue's major shareholders?

TrueBlue's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.28%), Vanguard Group Inc. (12.30%), Dimensional Fund Advisors LP (6.84%), Pzena Investment Management LLC (4.93%), FMR LLC (4.02%) and ArrowMark Colorado Holdings LLC (3.80%). Company insiders that own TrueBlue stock include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, Richard Christensen, Steven C Cooper and Taryn R Owen.
View institutional ownership trends for TrueBlue
.

Which institutional investors are selling TrueBlue stock?

TBI stock was sold by a variety of institutional investors in the last quarter, including ArrowMark Colorado Holdings LLC, BlackRock Inc., Dimensional Fund Advisors LP, Bank of America Corp DE, Prudential Financial Inc., Citadel Advisors LLC, Hotchkis & Wiley Capital Management LLC, and Cubist Systematic Strategies LLC. Company insiders that have sold TrueBlue company stock in the last year include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, Richard Christensen, Steven C Cooper, and Taryn R Owen.
View insider buying and selling activity for TrueBlue
or view top insider-selling stocks.

Which institutional investors are buying TrueBlue stock?

TBI stock was purchased by a variety of institutional investors in the last quarter, including Artemis Investment Management LLP, Vanguard Group Inc., FMR LLC, Lord Abbett & CO. LLC, Invesco Ltd., Bank of Montreal Can, Parametric Portfolio Associates LLC, and Millennium Management LLC.
View insider buying and selling activity for TrueBlue
or or view top insider-buying stocks.

How do I buy shares of TrueBlue?

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TrueBlue's stock price today?

One share of TBI stock can currently be purchased for approximately $25.90.

How much money does TrueBlue make?

TrueBlue has a market capitalization of $919.53 million and generates $1.85 billion in revenue each year. The business services provider earns $-141,840,000.00 in net income (profit) each year or $0.43 on an earnings per share basis.

How many employees does TrueBlue have?

TrueBlue employs 5,200 workers across the globe.

What is TrueBlue's official website?

The official website for TrueBlue is www.trueblue.com.

Where are TrueBlue's headquarters?

TrueBlue is headquartered at 1015 A STREET, TACOMA WA, 98402.

How can I contact TrueBlue?

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at (253) 383-9101 or via email at [email protected].


This page was last updated on 9/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.